
Nancy Gillis 🆖☮️
@nancykgillis
Molecular Epi • PGx • Hematology • @MoffittNews • Ad Lib Mom • Cancer Hater • Dog Lover • Explorer • PharmD @UFPharmacy • PhD @UNCPharmacy *Opinions mine
ID: 1006984178917957638
13-06-2018 19:38:32
510 Tweet
275 Followers
357 Following

I'm super excited to share that our work on clonal hematopoiesis in the tumour microenvironment is now published in Cell Reports Medicine!! By tracking CH mutations from the blood into the tumour (CH-Tum), we uncovered some new insights about CH in solid cancer cell.com/cell-reports-m…



📢Our department, Cancer Epidemiology, is hiring. All strong applicants will be considered. Come work with us! Moffitt Research Moffitt Cancer Center …cancer-center-careers.hctsportals.com/jobs/1946077-t…



Wow, today is the day...excited to see this amazing work from Daniel Starczynowski and his lab out! The microbiome of clonal hematopoiesis patients! nature.com/articles/s4158…



Fascinating science & story around an ageing gut & interaction with CHIP clones by Daniel Starczynowski . Such cool science & potential for more studies to tease out its role in leukemic evolution UMiami Health System Sylvester Comprehensive Cancer Center




New paper in The Lancet eClinicalMedicine with James Brogan & Ashwin Kishtagari, MD Vanderbilt Health We found that cytopenia is a key step from #CHIP ➡️ myeloid neoplasm (MN). Cytopenia-free survival = a new CHIP trial endpoint? doi.org/10.1016/j.ecli…

Remarkable work by Yash Pershad and team on CHIP dynamics over 16 years in ~7,000 women out now in Blood Journals Portfolio! Longitudinal CHIP studies remain rare - this depth of follow-up is invaluable. Correlates and Consequences of Clonal Hematopoiesis Expansion Rate: A 16-Year


🚨 New paper in Nature Genetics ! How does cancer chemotherapy reshape the HSC landscape and drive the evolution of therapy-related myeloid neoplasms? We uncovered this process through single-colony WGS! See the full paper here! nature.com/articles/s4158…

This work appears back-to-back with a powerful study from Jyoti Nangalia and Mike Stratton (Wellcome Sanger Institute) profiling the impact of wide array of cytotoxic therapy on human hematopoiesis. 🔗 nature.com/articles/s4158…